Informing the historical record of experimental nonhuman primate infections with ebola virus: Genomic characterization of USAMRIID ebola virus/H.sapiens-tc/COD/1995/Kikwit-9510621 challenge stock "R4368" and its replacement "R4415"

Jeffrey R. Kugelman, Cynthia A. Rossi, Michael R. Wiley, Jason T. Ladner, Elyse R. Nagle, Bradley P. Pfeffer, Karla Garcia, Karla Prieto, Jiro Wada, Jens H. Kuhn, Gustavo Palacios

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The creation of licensed medical countermeasures against Select Agents such as Ebola virus (EBOV) is critically dependent on the use of standardized reagents, assays, and animal models. We performed full genome reconstruction, population genomics, contaminant analysis, and characterization of the glycoprotein gene editing site of historical United States Army Medical Research Institute of Infectious Diseases (USAMRIID) nonhuman-primate challenge stock Ebola virus Kikwit "R4368" and its 2014 replacement "R4415." We also provide characterization of the master stock used to create "R4415." The obtained data are essential to understanding the quality of the seed stock reagents used in pivotal animal studies that have been used to inform medical countermeasure development. Furthermore, these data might add to the understanding of the influence of EBOV variant populations on pathogenesis and disease outcome and inform attempts to avoid the evolution of EBOV escape mutants in response to current therapeutics. Finally, as the primary challenge stocks have changed over time, these data will provide a baseline for understanding and correlating past and future animal study results.

Original languageEnglish (US)
Article numbere0150919
JournalPloS one
Volume11
Issue number3
DOIs
StatePublished - Mar 2016

Fingerprint

Ebola Hemorrhagic Fever
Ebolavirus
biomedical research
Viruses
Primates
infectious diseases
Communicable Diseases
Biomedical Research
genomics
Animals
infection
Genes
historic sites
Metagenomics
seed quality
Seed
glycoproteins
Assays
Seeds
Glycoproteins

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)
  • General

Cite this

Informing the historical record of experimental nonhuman primate infections with ebola virus : Genomic characterization of USAMRIID ebola virus/H.sapiens-tc/COD/1995/Kikwit-9510621 challenge stock "R4368" and its replacement "R4415". / Kugelman, Jeffrey R.; Rossi, Cynthia A.; Wiley, Michael R.; Ladner, Jason T.; Nagle, Elyse R.; Pfeffer, Bradley P.; Garcia, Karla; Prieto, Karla; Wada, Jiro; Kuhn, Jens H.; Palacios, Gustavo.

In: PloS one, Vol. 11, No. 3, e0150919, 03.2016.

Research output: Contribution to journalArticle

Kugelman, Jeffrey R. ; Rossi, Cynthia A. ; Wiley, Michael R. ; Ladner, Jason T. ; Nagle, Elyse R. ; Pfeffer, Bradley P. ; Garcia, Karla ; Prieto, Karla ; Wada, Jiro ; Kuhn, Jens H. ; Palacios, Gustavo. / Informing the historical record of experimental nonhuman primate infections with ebola virus : Genomic characterization of USAMRIID ebola virus/H.sapiens-tc/COD/1995/Kikwit-9510621 challenge stock "R4368" and its replacement "R4415". In: PloS one. 2016 ; Vol. 11, No. 3.
@article{afcaf2da76e14cdb9924488b2c51c50b,
title = "Informing the historical record of experimental nonhuman primate infections with ebola virus: Genomic characterization of USAMRIID ebola virus/H.sapiens-tc/COD/1995/Kikwit-9510621 challenge stock {"}R4368{"} and its replacement {"}R4415{"}",
abstract = "The creation of licensed medical countermeasures against Select Agents such as Ebola virus (EBOV) is critically dependent on the use of standardized reagents, assays, and animal models. We performed full genome reconstruction, population genomics, contaminant analysis, and characterization of the glycoprotein gene editing site of historical United States Army Medical Research Institute of Infectious Diseases (USAMRIID) nonhuman-primate challenge stock Ebola virus Kikwit {"}R4368{"} and its 2014 replacement {"}R4415.{"} We also provide characterization of the master stock used to create {"}R4415.{"} The obtained data are essential to understanding the quality of the seed stock reagents used in pivotal animal studies that have been used to inform medical countermeasure development. Furthermore, these data might add to the understanding of the influence of EBOV variant populations on pathogenesis and disease outcome and inform attempts to avoid the evolution of EBOV escape mutants in response to current therapeutics. Finally, as the primary challenge stocks have changed over time, these data will provide a baseline for understanding and correlating past and future animal study results.",
author = "Kugelman, {Jeffrey R.} and Rossi, {Cynthia A.} and Wiley, {Michael R.} and Ladner, {Jason T.} and Nagle, {Elyse R.} and Pfeffer, {Bradley P.} and Karla Garcia and Karla Prieto and Jiro Wada and Kuhn, {Jens H.} and Gustavo Palacios",
year = "2016",
month = "3",
doi = "10.1371/journal.pone.0150919",
language = "English (US)",
volume = "11",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "3",

}

TY - JOUR

T1 - Informing the historical record of experimental nonhuman primate infections with ebola virus

T2 - Genomic characterization of USAMRIID ebola virus/H.sapiens-tc/COD/1995/Kikwit-9510621 challenge stock "R4368" and its replacement "R4415"

AU - Kugelman, Jeffrey R.

AU - Rossi, Cynthia A.

AU - Wiley, Michael R.

AU - Ladner, Jason T.

AU - Nagle, Elyse R.

AU - Pfeffer, Bradley P.

AU - Garcia, Karla

AU - Prieto, Karla

AU - Wada, Jiro

AU - Kuhn, Jens H.

AU - Palacios, Gustavo

PY - 2016/3

Y1 - 2016/3

N2 - The creation of licensed medical countermeasures against Select Agents such as Ebola virus (EBOV) is critically dependent on the use of standardized reagents, assays, and animal models. We performed full genome reconstruction, population genomics, contaminant analysis, and characterization of the glycoprotein gene editing site of historical United States Army Medical Research Institute of Infectious Diseases (USAMRIID) nonhuman-primate challenge stock Ebola virus Kikwit "R4368" and its 2014 replacement "R4415." We also provide characterization of the master stock used to create "R4415." The obtained data are essential to understanding the quality of the seed stock reagents used in pivotal animal studies that have been used to inform medical countermeasure development. Furthermore, these data might add to the understanding of the influence of EBOV variant populations on pathogenesis and disease outcome and inform attempts to avoid the evolution of EBOV escape mutants in response to current therapeutics. Finally, as the primary challenge stocks have changed over time, these data will provide a baseline for understanding and correlating past and future animal study results.

AB - The creation of licensed medical countermeasures against Select Agents such as Ebola virus (EBOV) is critically dependent on the use of standardized reagents, assays, and animal models. We performed full genome reconstruction, population genomics, contaminant analysis, and characterization of the glycoprotein gene editing site of historical United States Army Medical Research Institute of Infectious Diseases (USAMRIID) nonhuman-primate challenge stock Ebola virus Kikwit "R4368" and its 2014 replacement "R4415." We also provide characterization of the master stock used to create "R4415." The obtained data are essential to understanding the quality of the seed stock reagents used in pivotal animal studies that have been used to inform medical countermeasure development. Furthermore, these data might add to the understanding of the influence of EBOV variant populations on pathogenesis and disease outcome and inform attempts to avoid the evolution of EBOV escape mutants in response to current therapeutics. Finally, as the primary challenge stocks have changed over time, these data will provide a baseline for understanding and correlating past and future animal study results.

UR - http://www.scopus.com/inward/record.url?scp=84962425718&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962425718&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0150919

DO - 10.1371/journal.pone.0150919

M3 - Article

C2 - 27002733

AN - SCOPUS:84962425718

VL - 11

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 3

M1 - e0150919

ER -